Biotech

All Articles

Analysts explore Avidity's DMD succeed, showing nuances in information

.Avidity Biosciences amazed capitalists along with period 1/2 records in Duchenne muscular dystrophy...

Actinogen's cortisol blocker fails stage 2 depression research study

.Actinogen Medical's cortisol blocker has actually missed out on the main endpoint of a stage 2 stud...

Bivictrix chooses going personal only method to take ADC in to center

.Antibody-drug conjugates (ADCs) have been at the center of lots of a billion-dollar biobuck licensi...

TPG tops up funds to $580M for financial investments throughout lifestyle sciences

.Property supervisor TPG, which has actually sustained biotechs including Sionna Rehabs and Santa Cl...

Merck quits phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT system has actually suffered one more obstacle. Months after shuttering a st...

After a challenging year, Exscientia folds into Recursion

.After a year described through pipeline hairstyles, the variation of its chief executive officer an...

Cullinan, after $25M bargain, hands back bispecific to Port

.Cullinan Therapy was actually blown away good enough along with Harbour BioMed's bispecific immune ...

A more detailed take a look at Ferocious Biotech's Tough 15

.In this full week's episode of "The Top Pipe," our company are actually diving right into Ferocious...

Lilly faces period 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party celebrating the approval of Al...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings as w...